1117 related articles for article (PubMed ID: 27759337)
1. Management Practices in Indian Patients with Uncontrolled Hypertension.
Bharatia R; Chitale M; Saxena GN; Kumar RG; Chikkalingaiah ; Trailokya A; Dalvi K; Talele S
J Assoc Physicians India; 2016 Jul; 64(7):14-21. PubMed ID: 27759337
[TBL] [Abstract][Full Text] [Related]
2. DemographIc Assessment and EValuation of DEgree of Lipid Control in High Risk Indian DySlipidemia PatiEnts (DIVERSE Study).
Malhotra N; Keshan MK; Agarwal A; Kumar RA; Trailokya A; Dalvi K; Talele S
J Assoc Physicians India; 2016 Apr; 64(4):38-46. PubMed ID: 27734640
[TBL] [Abstract][Full Text] [Related]
3. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
Neutel JM
Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
Cortez-Dias N; Martins S; Belo A; Fiuza M;
Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
6. Choice of antihypertensive medications among physicians and its impact on blood pressure control among Nigerians living with hypertension.
Mijinyawa Muhammad S; Yusuf MS; Mohammed H; Saidu H; Sulaiman BA; Uloko AE
Niger J Med; 2016; 25(3):220-5. PubMed ID: 30011166
[TBL] [Abstract][Full Text] [Related]
7. Medical treatment of hypertension in Switzerland. The 2009 Swiss Hypertension Survey (SWISSHYPE).
Brenner R; Waeber B; Allemann Y
Swiss Med Wkly; 2011; 141():w13169. PubMed ID: 21374529
[TBL] [Abstract][Full Text] [Related]
8. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
9. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
Chazova IE; Martynyuk TV
Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
[TBL] [Abstract][Full Text] [Related]
10. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of prescription and rationality of anti-hypertensive medication among community health centers in Beijing].
Bai JJ; Zhang WL; Wang L; Liu PY; Cai J
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Oct; 49(10):993-999. PubMed ID: 34674437
[No Abstract] [Full Text] [Related]
12. Patterns of anti-hypertensive therapy in diabetic patients with and without reduced renal function.
Sweileh WM; Sawalha AF; Zyoud SH; Al-Jabi SW; Tameem EJ
Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):652-9. PubMed ID: 20587868
[TBL] [Abstract][Full Text] [Related]
13. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
15. New strategies and drugs in the treatment of hypertension: monotherapy or combination?
Destro M; Cagnoni F; D'Ospina A; Ricci AR; Zaninelli A; Preti P
Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):69-81. PubMed ID: 20015049
[TBL] [Abstract][Full Text] [Related]
16. Negative predictors of treatment success in outpatient therapy of arterial hypertension in Poland. Results of the CONTROL NT observational registry.
Filipiak KJ; Tomaniak M; Płatek AE; Szymański FM; Tykarski A
Kardiol Pol; 2018; 76(2):353-361. PubMed ID: 29131289
[TBL] [Abstract][Full Text] [Related]
17. Blood Pressure Target Achievement Under Monotheraphy: A Real-Life Appraisal.
Tocci G; Presta V; Citoni B; Figliuzzi I; Bianchi F; Ferrucci A; Volpe M
High Blood Press Cardiovasc Prev; 2020 Dec; 27(6):587-596. PubMed ID: 33165768
[TBL] [Abstract][Full Text] [Related]
18. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
19. A prospective drug use evaluation of antihypertensive drugs in in-patients of a tertiary referral care hospital.
Mankadavath A; Chandrasekhar D; Thomas T; Zuhra F; Kaipanthodi S; Parambil JC
J Basic Clin Physiol Pharmacol; 2015 May; 26(3):295-300. PubMed ID: 25153590
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
Neutel J; Shojaee A; Maa JF
Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
